help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lesur, O.
Right arrow Articles by Lane, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lesur, O.
Right arrow Articles by Lane, D.

Am. J. Respir. Crit. Care Med., Vol 152, No. 1, 07 1995, 290-297.

Clara cell protein (CC-16) induces a phospholipase A2-mediated inhibition of fibroblast migration in vitro

O Lesur, A Bernard, K Arsalane, R Lauwerys, R Begin, A Cantin and D Lane
Unite de Recherche Pulmonaire, University of Sherbrooke, Quebec, Canada.

Clara cell protein (CC-16, also designated CC-10) is synthesized by the bronchiolar epithelium and has been suggested as an inhibitor of phospholipase A2 (PLA2) activity. Therefore, CC-16 is a candidate for controlling inflammatory events in the lung. Because CC-16 amounts and function may be altered in fibrosing lung diseases in which bronchiolar injury has been reported, it was measured in alveolar fluids and sera. Secretory PLA2 activity in alveolar fluids and the influence of CC-16 on platelet-derived growth factor-induced human fibroblast chemotaxis and cytosolic PLA2 activity were also explored. CC-16 content was decreased in alveolar fluids from idiopathic pulmonary fibrosis (IPF: 1.3 +/- 0.1 mg/L) and bleomycin lung (1.1 +/- 0.2 versus 2.1 +/- 0.2 mg/L in controls, p < 0.05), whereas there was a three- to ninefold increase in secretory PLA2 activity (p < 0.05 versus controls). CC-16 inhibited fibroblast chemotaxis in a dose-dependent manner (90% inhibition at 30 micrograms/ml CC-16). This inhibition was reversed by reducing CC-16. CC-16 was also able to lower fibroblastic cytosolic PLA2 activity by 50% in vitro. In summary, CC-16 is able to inhibit fibroblast chemotaxis in vitro by mechanisms that may be related to a blockage of cytosolic PLA2 activity. It can be postulated that CC-16 deficiency may contribute to fibroblast burden activity in fibrosing lung diseases.


This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
P. Chen, J. K. McGuire, R. C. Hackman, K.-H. Kim, R. A. Black, K. Poindexter, W. Yan, P. Liu, A. J. Chen, W. C. Parks, et al.
Tissue Inhibitor of Metalloproteinase-1 Moderates Airway Re-Epithelialization by Regulating Matrilysin Activity
Am. J. Pathol., May 1, 2008; 172(5): 1256 - 1270.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
A. B. Mukherjee, Z. Zhang, and B. S. Chilton
Uteroglobin: A Steroid-Inducible Immunomodulatory Protein That Founded the Secretoglobin Superfamily
Endocr. Rev., December 1, 2007; 28(7): 707 - 725.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
V. Starosta, F. Ratjen, E. Rietschel, K. Paul, and M. Griese
Anti-inflammatory cytokines in cystic fibrosis lung disease
Eur. Respir. J., September 1, 2006; 28(3): 581 - 587.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K.-S. Kim, S. Sengupta, M. Berk, Y.-G. Kwak, P. F. Escobar, J. Belinson, S. C. Mok, and Y. Xu
Hypoxia Enhances Lysophosphatidic Acid Responsiveness in Ovarian Cancer Cells and Lysophosphatidic Acid Induces Ovarian Tumor Metastasis In vivo
Cancer Res., August 15, 2006; 66(16): 7983 - 7990.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
B. N. Shashikant, T. L. Miller, R. W. Welch, A. L. Pilon, T. H. Shaffer, and M. R. Wolfson
Dose response to rhCC10-augmented surfactant therapy in a lamb model of infant respiratory distress syndrome: physiological, inflammatory, and kinetic profiles
J Appl Physiol, December 1, 2005; 99(6): 2204 - 2211.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
S. Yoshikawa, T. Miyahara, S. D. Reynolds, B. R. Stripp, M. Anghelescu, F. G. Eyal, and J. C. Parker
Clara cell secretory protein and phospholipase A2 activity modulate acute ventilator-induced lung injury in mice
J Appl Physiol, April 1, 2005; 98(4): 1264 - 1271.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
T. Betsuyaku, Y. Kuroki, K. Nagai, Y. Nasuhara, and M. Nishimura
Effects of ageing and smoking on SP-A and SP-D levels in bronchoalveolar lavage fluid
Eur. Respir. J., December 1, 2004; 24(6): 964 - 970.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. Janssen, H. Sato, J. C. Grutters, H. J. T. Ruven, R. M. du Bois, R. Matsuura, M. Yamazaki, S. Kunimaru, T. Izumi, K. I. Welsh, et al.
The Clara Cell10 Adenine38Guanine Polymorphism and Sarcoidosis Susceptibility in Dutch and Japanese Subjects
Am. J. Respir. Crit. Care Med., December 1, 2004; 170(11): 1185 - 1187.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
T. Ohchi, N. Shijubo, I. Kawabata, S. Ichimiya, S.-i. Inomata, A. Yamaguchi, Y. Umemori, Y. Itoh, S. Abe, Y. Hiraga, et al.
Polymorphism of Clara Cell 10-kD Protein Gene of Sarcoidosis
Am. J. Respir. Crit. Care Med., January 15, 2004; 169(2): 180 - 186.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
R. Janssen, H. Sato, J. C. Grutters, A. Bernard, H. van Velzen-Blad, R. M. du Bois, and J. M. M. van den Bosch
Study of Clara Cell 16, KL-6, and Surfactant Protein-D in Serum as Disease Markers in Pulmonary Sarcoidosis
Chest, December 1, 2003; 124(6): 2119 - 2125.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
M. Yu, X. Zheng, H. Witschi, and K. E. Pinkerton
The Role of Interleukin-6 in Pulmonary Inflammation and Injury Induced by Exposure to Environmental Air Pollutants
Toxicol. Sci., August 1, 2002; 68(2): 488 - 497.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
K. J. Haley, A. Ciota, J. P. Contreras, M. R. Boothby, D. L. Perkins, and P. W. Finn
Alterations in lung collectins in an adaptive allergic immune response
Am J Physiol Lung Cell Mol Physiol, March 1, 2002; 282(3): L573 - L584.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L.-C. Chen, Z. Zhang, A. C. Myers, and S.-K. Huang
Cutting Edge: Altered Pulmonary Eosinophilic Inflammation in Mice Deficient for Clara Cell Secretory 10-kDa Protein
J. Immunol., September 15, 2001; 167(6): 3025 - 3028.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
C. Hermans, M. Petrek, V. Kolek, B. Weynand, T. Pieters, M. Lambert, and A. Bernard
Serum Clara cell protein (CC16), a marker of the integrity of the air-blood barrier in sarcoidosis
Eur. Respir. J., September 1, 2001; 18(3): 507 - 514.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
A. L. PILON
Rationale for the Development of Recombinant Human CC10 as a Therapeutic for Inflammatory and Fibrotic Disease
Ann. N.Y. Acad. Sci., December 1, 2000; 923(1): 280 - 299.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
K. ARSALANE, F. BROECKAERT, B. KNOOPS, M. WIEDIG, G. TOUBEAU, and A. BERNARD
Clara Cell Specific Protein (CC16) Expression after Acute Lung Inflammation Induced by Intratracheal Lipopolysaccharide Administration
Am. J. Respir. Crit. Care Med., May 1, 2000; 161(5): 1624 - 1630.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
N. SHIJUBO, Y. ITOH, T. YAMAGUCHI, A. IMADA, M. HIRASAWA, T. YAMADA, T. KAWAI, and S. ABE
Clara Cell Protein-positive Epithelial Cells Are Reduced in Small Airways of Asthmatics
Am. J. Respir. Crit. Care Med., September 1, 1999; 160(3): 930 - 933.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. HERMANS and A. BERNARD
Lung Epithelium-specific Proteins . Characteristics and Potential Applications as Markers
Am. J. Respir. Crit. Care Med., February 1, 1999; 159(2): 646 - 678.
[Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
I. R. DOYLE, C. HERMANS, A. BERNARD, T. E. NICHOLAS, and A. D. BERSTEN
Clearance of Clara Cell Secretory Protein 16 (CC16) and Surfactant Proteins A and B from Blood in Acute Respiratory Failure
Am. J. Respir. Crit. Care Med., November 1, 1998; 158(5): 1528 - 1535.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
X. L. Yao, S. J. Levine, M. J. Cowan, C. Logun, and J. H. Shelhamer
Tumor Necrosis Factor-alpha Stimulates Human Clara Cell Secretory Protein Production by Human Airway Epithelial Cells
Am. J. Respir. Cell Mol. Biol., October 1, 1998; 19(4): 629 - 635.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
X. L. Yao, T. Ikezono, M. Cowan, C. Logun, C. W. Angus, and J. H. Shelhamer
Interferon-gamma stimulates human Clara cell secretory protein production by human airway epithelial cells
Am J Physiol Lung Cell Mol Physiol, May 1, 1998; 274(5): L864 - L869.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. HERMANS, O. LESUR, B. WEYNAND, TH. PIETERS, M. LAMBERT, and A. BERNARD
Clara Cell Protein (CC16) in Pleural Fluids . A Marker of Leakage through the Visceral Pleura
Am. J. Respir. Crit. Care Med., March 1, 1998; 157(3): 962 - 969.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1995 American Thoracic Society